Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Clinical trial NCT00084656 · COMPLETED

Trial details

NCT number: NCT00084656
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intraocular Melanoma Melanoma (Skin)

Start date: 2004-05-31
Primary completion: 2009-10-31
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.